Cargando…

A quality by design approach for the synthesis of palmitoyl-L-carnitine-loaded nanoemulsions as drug delivery systems

Nanoemulsions (NE) are lipid nanocarriers that can efficiently load hydrophobic active compounds, like palmitoyl-L-carnitine (pC), used here as model molecule. The use of design of experiments (DoE) approach is a useful tool to develop NEs with optimized properties, requiring less experiments compar...

Descripción completa

Detalles Bibliográficos
Autores principales: Arroyo-Urea, E. M., Muñoz-Hernando, María, Leo-Barriga, Marta, Herranz, Fernando, González-Paredes, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184586/
https://www.ncbi.nlm.nih.gov/pubmed/36803136
http://dx.doi.org/10.1080/10717544.2023.2179128
_version_ 1785042175813222400
author Arroyo-Urea, E. M.
Muñoz-Hernando, María
Leo-Barriga, Marta
Herranz, Fernando
González-Paredes, Ana
author_facet Arroyo-Urea, E. M.
Muñoz-Hernando, María
Leo-Barriga, Marta
Herranz, Fernando
González-Paredes, Ana
author_sort Arroyo-Urea, E. M.
collection PubMed
description Nanoemulsions (NE) are lipid nanocarriers that can efficiently load hydrophobic active compounds, like palmitoyl-L-carnitine (pC), used here as model molecule. The use of design of experiments (DoE) approach is a useful tool to develop NEs with optimized properties, requiring less experiments compared to trial-and-error approach. In this work, NE were prepared by the solvent injection technique and DoE using a two-level fractional factorial design (FFD) as model was implemented for designing pC-loaded NE. NEs were fully characterized by a combination of techniques, studying its stability, scalability, pC entrapment and loading capacity and biodistribution, which was studied ex-vivo after injection of fluorescent NEs in mice. We selected the optimal composition for NE, named pC-NE(U), after analysis of four variables using DoE. pC-NE(U) incorporated pC in a very efficient manner, with high entrapment efficiency (EE) and loading capacity. pC-NE(U) did not change its initial colloidal properties stored at 4 °C in water during 120 days, nor in buffers with different pH values (5.3 and 7.4) during 30 days. Moreover, the scalability process did not affect NE properties and stability profile. Finally, biodistribution study showed that pC-NE(U) formulation was predominantly concentrated in the liver, with minimal accumulation in spleen, stomach, and kidneys.
format Online
Article
Text
id pubmed-10184586
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-101845862023-05-16 A quality by design approach for the synthesis of palmitoyl-L-carnitine-loaded nanoemulsions as drug delivery systems Arroyo-Urea, E. M. Muñoz-Hernando, María Leo-Barriga, Marta Herranz, Fernando González-Paredes, Ana Drug Deliv Research Article Nanoemulsions (NE) are lipid nanocarriers that can efficiently load hydrophobic active compounds, like palmitoyl-L-carnitine (pC), used here as model molecule. The use of design of experiments (DoE) approach is a useful tool to develop NEs with optimized properties, requiring less experiments compared to trial-and-error approach. In this work, NE were prepared by the solvent injection technique and DoE using a two-level fractional factorial design (FFD) as model was implemented for designing pC-loaded NE. NEs were fully characterized by a combination of techniques, studying its stability, scalability, pC entrapment and loading capacity and biodistribution, which was studied ex-vivo after injection of fluorescent NEs in mice. We selected the optimal composition for NE, named pC-NE(U), after analysis of four variables using DoE. pC-NE(U) incorporated pC in a very efficient manner, with high entrapment efficiency (EE) and loading capacity. pC-NE(U) did not change its initial colloidal properties stored at 4 °C in water during 120 days, nor in buffers with different pH values (5.3 and 7.4) during 30 days. Moreover, the scalability process did not affect NE properties and stability profile. Finally, biodistribution study showed that pC-NE(U) formulation was predominantly concentrated in the liver, with minimal accumulation in spleen, stomach, and kidneys. Taylor & Francis 2023-02-19 /pmc/articles/PMC10184586/ /pubmed/36803136 http://dx.doi.org/10.1080/10717544.2023.2179128 Text en © 2023 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.
spellingShingle Research Article
Arroyo-Urea, E. M.
Muñoz-Hernando, María
Leo-Barriga, Marta
Herranz, Fernando
González-Paredes, Ana
A quality by design approach for the synthesis of palmitoyl-L-carnitine-loaded nanoemulsions as drug delivery systems
title A quality by design approach for the synthesis of palmitoyl-L-carnitine-loaded nanoemulsions as drug delivery systems
title_full A quality by design approach for the synthesis of palmitoyl-L-carnitine-loaded nanoemulsions as drug delivery systems
title_fullStr A quality by design approach for the synthesis of palmitoyl-L-carnitine-loaded nanoemulsions as drug delivery systems
title_full_unstemmed A quality by design approach for the synthesis of palmitoyl-L-carnitine-loaded nanoemulsions as drug delivery systems
title_short A quality by design approach for the synthesis of palmitoyl-L-carnitine-loaded nanoemulsions as drug delivery systems
title_sort quality by design approach for the synthesis of palmitoyl-l-carnitine-loaded nanoemulsions as drug delivery systems
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10184586/
https://www.ncbi.nlm.nih.gov/pubmed/36803136
http://dx.doi.org/10.1080/10717544.2023.2179128
work_keys_str_mv AT arroyoureaem aqualitybydesignapproachforthesynthesisofpalmitoyllcarnitineloadednanoemulsionsasdrugdeliverysystems
AT munozhernandomaria aqualitybydesignapproachforthesynthesisofpalmitoyllcarnitineloadednanoemulsionsasdrugdeliverysystems
AT leobarrigamarta aqualitybydesignapproachforthesynthesisofpalmitoyllcarnitineloadednanoemulsionsasdrugdeliverysystems
AT herranzfernando aqualitybydesignapproachforthesynthesisofpalmitoyllcarnitineloadednanoemulsionsasdrugdeliverysystems
AT gonzalezparedesana aqualitybydesignapproachforthesynthesisofpalmitoyllcarnitineloadednanoemulsionsasdrugdeliverysystems
AT arroyoureaem qualitybydesignapproachforthesynthesisofpalmitoyllcarnitineloadednanoemulsionsasdrugdeliverysystems
AT munozhernandomaria qualitybydesignapproachforthesynthesisofpalmitoyllcarnitineloadednanoemulsionsasdrugdeliverysystems
AT leobarrigamarta qualitybydesignapproachforthesynthesisofpalmitoyllcarnitineloadednanoemulsionsasdrugdeliverysystems
AT herranzfernando qualitybydesignapproachforthesynthesisofpalmitoyllcarnitineloadednanoemulsionsasdrugdeliverysystems
AT gonzalezparedesana qualitybydesignapproachforthesynthesisofpalmitoyllcarnitineloadednanoemulsionsasdrugdeliverysystems